The Board of Directors of the Company('Board') at its meeting held on 23 June 2023, inter-alia considered and approved the following business items: 1. Approval of Scheme of Amalgamation with Shilpa Therapeutics Private Limited (A Wholly Owned Subsidiary Company). Draft Scheme of Amalgamation between Shilpa Medicare limited & Shilpa Therapeutics Private Limited being a wholly owned Subsidiary Company (As per BSE Announcement Dated on 27/10/2023) NCLT order on merger of Shilpa Therapeutics Private Limited a wholly owned subsidiary with Shilpa Media Limited. (As per BSE announcement dated on :05.03.2026) Intimation of certified true copy of NCLT Order approving the Scheme of amalgamation. (As Per BSE Announcement Dated on:17.03.2026)